Holen Sie sich die Stockscreener-App
9.82
0.72%
0.07
Handel nachbörslich:
9.82
Schlusskurs vom Vortag:
$9.75
Offen:
$9.79
24-Stunden-Volumen:
83,861
Relative Volume:
0.78
Marktkapitalisierung:
$141.59M
Einnahmen:
$166.88M
Nettoeinkommen (Verlust:
$-74.18M
KGV:
-1.9369
EPS:
-5.07
Netto-Cashflow:
$1.14M
1W Leistung:
+1.24%
1M Leistung:
+8.27%
6M Leistung:
-33.87%
1J Leistung:
-40.59%
1-Tages-Spanne:
$9.6117
$9.94
1-Wochen-Bereich:
$9.585
$9.9698
52-Wochen-Spanne:
$7.8701
$18.37
Anika Therapeutics Inc Stock (ANIK) Company Profile
Firmenname
Anika Therapeutics Inc
Sektor
Telefon
(781) 457-9000
Adresse
32 WIGGINS AVENUE, BEDFORD, MA
Vergleichen Sie ANIK mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ANIK
Anika Therapeutics Inc
|
9.82 | 140.58M | 166.88M | -74.18M | 1.14M | -5.07 |
|
ZTS
Zoetis Inc
|
144.35 | 63.86B | 9.39B | 2.62B | 2.22B | 5.8121 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.42 | 42.46B | 29.96B | 957.25M | 4.77B | 0.2956 |
|
HLN
Haleon Plc Adr
|
9.38 | 41.28B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
20.52 | 23.49B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
438.66 | 19.18B | 3.08B | 1.24B | 1.07B | 25.61 |
Anika Therapeutics Inc Stock (ANIK) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-04-17 | Eingeleitet | B. Riley Securities | Buy |
| 2024-11-01 | Bestätigt | Barrington Research | Outperform |
| 2023-08-14 | Hochstufung | Barrington Research | Mkt Perform → Outperform |
| 2023-03-07 | Herabstufung | Barrington Research | Outperform → Mkt Perform |
| 2022-11-09 | Hochstufung | Barrington Research | Mkt Perform → Outperform |
| 2022-10-14 | Fortgesetzt | Stephens | Equal-Weight |
| 2022-03-09 | Herabstufung | Barrington Research | Outperform → Mkt Perform |
| 2022-03-09 | Herabstufung | Stephens | Overweight → Equal-Weight |
| 2021-11-16 | Eingeleitet | Stephens | Overweight |
| 2021-07-16 | Eingeleitet | UBS | Neutral |
| 2020-12-16 | Hochstufung | Barrington Research | Mkt Perform → Outperform |
| 2020-05-08 | Herabstufung | Barrington Research | Outperform → Mkt Perform |
| 2020-01-21 | Hochstufung | Sidoti | Neutral → Buy |
| 2020-01-10 | Hochstufung | First Analysis Sec | Outperform → Strong Buy |
| 2019-11-05 | Eingeleitet | BWS Financial | Sell |
| 2019-09-24 | Bestätigt | Barrington Research | Outperform |
| 2019-09-23 | Herabstufung | First Analysis Sec | Strong Buy → Outperform |
| 2019-07-25 | Hochstufung | First Analysis Sec | Neutral → Strong Buy |
| 2019-02-22 | Herabstufung | First Analysis Sec | Outperform → Neutral |
| 2019-02-22 | Herabstufung | Sidoti | Buy → Neutral |
| 2018-07-27 | Hochstufung | Barrington Research | Mkt Perform → Outperform |
| 2018-06-20 | Herabstufung | Barrington Research | Outperform → Mkt Perform |
| 2018-06-20 | Herabstufung | First Analysis Sec | Overweight → Equal-Weight |
| 2018-05-04 | Hochstufung | Barrington Research | Mkt Perform → Outperform |
| 2018-02-23 | Herabstufung | Barrington Research | Outperform → Mkt Perform |
| 2018-01-24 | Hochstufung | First Analysis Sec | Equal-Weight → Overweight |
| 2017-10-27 | Bestätigt | Barrington Research | Outperform |
| 2016-05-09 | Hochstufung | Singular Research | BUY - Long-Term → Buy |
| 2016-04-27 | Herabstufung | Northland Capital | Outperform → Market Perform |
| 2016-02-26 | Bestätigt | Barrington Research | Outperform |
Alle ansehen
Anika Therapeutics Inc Aktie (ANIK) Neueste Nachrichten
Anika Therapeutics Inc expected to post a loss of 27 cents a shareEarnings Preview - TradingView
Why Anika Therapeutics Inc. stock could rally in 20252025 Market Overview & AI Enhanced Execution Alerts - newser.com
Strategies to average down on Anika Therapeutics Inc.July 2025 Gainers & Free Real-Time Volume Trigger Notifications - newser.com
Does Anika Therapeutics Inc. show high probability of rebound2025 Performance Recap & Comprehensive Market Scan Insights - newser.com
Using AI based signals to follow Anika Therapeutics Inc.Profit Target & Technical Pattern Based Signals - newser.com
What dividend safety rating applies to Anika Therapeutics Inc. (AKP) stockCEO Change & Free High Return Stock Watch Alerts - newser.com
Detecting support and resistance levels for Anika Therapeutics Inc.Market Performance Recap & Advanced Technical Signal Analysis - newser.com
Will Anika Therapeutics Inc. stock reach all time highs in 2025Share Buyback & Free Verified High Yield Trade Plans - newser.com
Why Anika Therapeutics Inc. stock could outperform in 2025Weekly Profit Report & Reliable Volume Spike Trade Alerts - newser.com
Is Anika Therapeutics Inc. stock positioned for long term growthPortfolio Value Summary & Stock Portfolio Risk Management - newser.com
What is the fair value estimate for Anika Therapeutics Inc. (AKP) stock in 2025Bull Run & Safe Capital Growth Plans - newser.com
Anika Therapeutics Inc. (ANIK) Stock forecasts - Yahoo! Finance UK
Published on: 2025-11-02 07:06:18 - newser.com
Anika Therapeutics Inc. (ANIK) stock forecast and price target - Yahoo! Finance UK
Anika Therapeutics, Inc. (ANIK) Analyst insights, Price targets and Recommendations - Yahoo! Finance UK
Anika Therapeutics, Inc. (ANIK) Analyst Insights, Price Targets & Recommendations - Yahoo! Finance Canada
Is Anika Therapeutics Inc. stock supported by strong cash flowsEntry Point & Low Drawdown Trading Strategies - newser.com
Anika Therapeutics (NASDAQ:ANIK) Earns Sell (D-) Rating from Weiss Ratings - MarketBeat
Key metrics from Anika Therapeutics Inc.’s quarterly data2025 Winners & Losers & Verified Technical Signals - newser.com
How to escape a deep drawdown in Anika Therapeutics Inc.2025 Growth vs Value & Smart Allocation Stock Reports - newser.com
Anika Therapeutics, Inc. (NASDAQ:ANIK) is a favorite amongst institutional investors who own 60% - Yahoo Finance
Can Anika Therapeutics Inc. stock sustain revenue growth2025 Momentum Check & Real-Time Price Movement Reports - fcp.pa.gov.br
Finanzdaten der Anika Therapeutics Inc-Aktie (ANIK)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.35%
0.90%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):